Recombinant human erythropoietin in amyotrophic lateral sclerosis: a pilot study of safety and feasibility.
about
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis.Socioeconomic costs of amyotrophic lateral sclerosis according to staging system.Translation and Psychometric Evaluation of a Korean Version of the Amyotrophic Lateral Sclerosis-Specific Quality of Life - Revised.Erythropoietin accelerates functional recovery after moderate sciatic nerve crush injury.
P2860
Recombinant human erythropoietin in amyotrophic lateral sclerosis: a pilot study of safety and feasibility.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Recombinant human erythropoiet ...... udy of safety and feasibility.
@en
type
label
Recombinant human erythropoiet ...... udy of safety and feasibility.
@en
prefLabel
Recombinant human erythropoiet ...... udy of safety and feasibility.
@en
P2093
P2860
P1476
Recombinant human erythropoiet ...... udy of safety and feasibility.
@en
P2093
Chanil Moon
Hyun Young Kim
Ki Wook Oh
Kyung Suk Kim
P2860
P304
P356
10.3988/JCN.2014.10.4.342
P577
2014-10-06T00:00:00Z